Quantify Research has supported the Swedish Association of the Pharmaceutical Industry (LIF) to re-analyse the EFPIA 2017 Patients W.A.I.T. Indicator for new medicines. We found that about 1/3 of EMA approved medicines are not available in Sweden. Some of these […]
On June 11th Anders Gustavsson attended a productive meeting at Edinburgh University on priority outcomes in Alzheimer’s disease. This effort is part of the IMI ROADMAP project aiming to improve the use of RWE in Alzheimer’s disease.
Visit the […]
Looking for tools and resources to support and inform HTA? Quantify recommends ISPOR’s HTA Resource Center – a previously available website which has been updated to allow for easier access to key HTA articles, […]
Having an Excel health economic model with a user-friendly interface and nice result charts is all well and good but how do you implement structural changes to it and deploy it to the members of your team? And while communicating […]
Quantify will be represented at this year’s WCO-IOF-ESCEO congress (the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases) by Fredrik Borgström and Gustaf Ortsäter. The posters “Prior Fracture Cascade and Incidence of Imminent Fracture After Fragility […]
In the world of market access, a large amount of resources go into engineering all-singing, all-dancing global models with a clean look and friendly user interface while simultaneously providing value to local affiliates. Although this feat is certainly an accomplishment, […]